Spirogen has a broad range of products in its pipeline in pre-clinical development and one compound, SG2000 is about to enter Phase II trials.
| Agent | Indication | Stage of Development | |||
| Discovery | Pre-clinical | Phase One | Phase Two | ||
| SG2000 | ONCOLOGY |  |
|||
| SG2285 | ONCOLOGY | |
|||
| AS-1-145 | ONCOLOGY | |
|||
| SGADC | Drug-conjugate | |
|||